Antihemophilic Factor (Recombinant [Fc Fusion Protein]) and Dabigatran
Determining the interaction of Antihemophilic Factor (Recombinant [Fc Fusion Protein]) and Dabigatran and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: dabigatran
Brand name: Pradaxa
Synonyms: Dabigatran Etexilate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Dabigatran Etexilate
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Dabigatran Etexilate Mesylate
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Dabrafenib
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Dabrafenib Mesylate
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Dacarbazine
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Dacarbazine Intravenous, Injection
- Dabigatran-Antihemophilic Factor (Recombinant [Pegylated-aucl])
- Dabigatran-Antihemophilic Factor (Recombinant [Pegylated])
- Dabigatran-Antihemophilic Factor (Recombinant [Pegylated]) Injection
- Dabigatran-Antihemophilic Factor (Recombinant [Porcine Sequence])
- Dabigatran-Antihemophilic Factor (Recombinant) (Advate)
- Dabigatran-Antihemophilic Factor (Recombinant) (Afstyla)